Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Vascular Pharmacology
  4. Fast Track Articles
  5. Fast Track Article
image of Evaluation of Cardiovascular and Hepatic Changes in Myocardial Infarction Patients Post-Covid-19 Vaccination

Abstract

Introduction

The global COVID-19 vaccination campaign has significantly reduced severe illness and mortality; however, emerging evidence raises concerns regarding its potential cardiovascular effects, particularly myocardial infarction (MI).

Method

This study investigates the relationship between COVID-19 vaccination and MI incidence among first-time MI patients in Saudi Arabia. Post-COVID-19 vaccination within six months post-vaccination accounted for potential confounding factors, such as pre-existing health conditions, age, and lifestyle. A total of 102 MI patients, with a male predominance of 60.8% and a significant correlation with middle age, were analysed. A+ blood group patients were the most prevalent (33.3%), followed by B+ (29.4%), while Rh-negative patients constituted only 7.8%. Elevated mean BNP (761.98 pg/ml), pulse rate (87.72 bpm), and systolic blood pressure (139.98 mmHg) indicated heightened cardiac stress (p < 0.01).

Results

Significant elevations in AST (121.65 U/L) and ALT (133.63 U/L) levels suggested liver stress post-Covid-19 vaccination (p < 0.01). Males had higher AST, ALT, and bilirubin levels than females, with p-values of 0.02, 0.01, and 0.04, respectively, indicating hepatic differences. Elevated biomarkers like CK-MB (58.05 IU/L) and CPK (313.86 mcg/L) further affirmed significant myocardial damage post-vaccination (p < 0.05).

Conclusion

These findings suggest a link between vaccination and cardiovascular events and highlight the importance of considering individual health profiles in evaluating vaccine safety, cardiovascular health, and hepatic implications.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cvp/10.2174/0115701611362338250214103331
2025-02-19
2025-06-20

  • From This Site

    /content/journals/cvp/10.2174/0115701611362338250214103331
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Alqahtani T.M.M. Ali Alghamdi M.A. Rafi Baig M. Al-Abbasi F.A. Sheikh R.A. Almalki N.A.R. Hejazi M.M. Alhayyani S. Asar T.O. Kumar V. Anwar F. Recent patterns and assessment of long-term complications following SARS-CoV-2 infection and vaccination in the context of diabet es prevalence among blood donors. Curr. Diabetes Rev. 2024 20 9 e110124225520 10.2174/0115733998274390231110050809 38415496
    [Google Scholar]
  2. Razzaque M.S. Can adverse cardiac events of the COVID-19 vaccine exacerbate preexisting diseases? Expert Rev. Anti Infect. Ther. 2024 22 4 131 137 10.1080/14787210.2024.2311837 38284355
    [Google Scholar]
  3. Cruz Rodriguez J.B. Lange R.A. Mukherjee D. Gamut of cardiac manifestations and complications of COVID-19: A contemporary review. J. Investig. Med. 2020 68 8 1334 1340 10.1136/jim‑2020‑001592 33077488
    [Google Scholar]
  4. Blasco A. Royuela A. García-Gómez S. Gómez-Lozano N. Sánchez-Arjona A. de la Fuente J. Anel J. Sánchez-Galarraga I. Pérez-Redondo M. González E. Silva L. Association of SARS-CoV-2 immunoserology and vaccination status with myocardial infarction severity and outcome. Vaccine 2024 42 26 126305 10.1016/j.vaccine.2024.126305 39244425
    [Google Scholar]
  5. Elizalde M.U. Eguinoa F.J.G. de las Huertas A.G.L. Jiménez-González M. Ramírez E. Myocarditis and pericarditis risk with mRNA COVID-19 vaccination compared to unvaccinated individuals: A retrospective cohort study in a Spanish Tertiary Hospital. Biomed. Pharmacother. 2024 171 116181 10.1016/j.biopha.2024.116181 38262150
    [Google Scholar]
  6. Keller K. Sagoschen I. Konstantinides S. Gori T. Münzel T. Hobohm L. Incidence and risk factors of myocarditis in hospitalized patients with COVID‐19. J. Med. Virol. 2023 95 3 e28646 10.1002/jmv.28646 36892180
    [Google Scholar]
  7. Rodriguez J.J. Munoz O.C. Porres-Aguilar M. Mukherjee D. Thromboembolic complications in severe COVID-19: Current antithrombotic strategies and future perspectives. Cardiovasc. Hematol. Disord. Drug Targets 2021 21 1 23 29 10.2174/1871529X21666210315123347 33719953
    [Google Scholar]
  8. Halmans L. Venhorst A. Klemis V. Schmidt T. Greiß F. Sester U. Gärtner B.C. Sester M. Meyer T. Immune response to COVID-19 vaccination in elite athletes. Exerc. Immunol. Rev. 2024 30 63 70 39094182
    [Google Scholar]
  9. McGonagle D. Giryes S. Immunology of coronary atherosclerosis and unexplained sudden death in the COVID-19 era. Autoimmun. Rev. 2024 ••• 103642 10.1016/j.autrev.2024.103642 39313122
    [Google Scholar]
  10. Li Y. Cao G. Jing W. Liu J. Liu M. Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990−2019: Findings from 2019 global burden of disease study. Eur. J. Prev. Cardiol. 2023 30 3 276 286 10.1093/eurjpc/zwac285 36458973
    [Google Scholar]
  11. Gaidai O. Cao Y. Loginov S. Global cardiovascular diseases death rate prediction. Curr. Probl. Cardiol. 2023 48 5 101622 10.1016/j.cpcardiol.2023.101622 36724816
    [Google Scholar]
  12. Ghamdi F.A. Naqvi S. Alabassi F.A. Alhayyani S. Baig M.R. Kumar V. Anwar F. Alterations in clinical characteristics of blood donors post COVID-19 recovery. Curr. Pharm. Des. 2022 28 12 981 992 10.2174/1381612828666220322123225 35319357
    [Google Scholar]
  13. Li J. Li W. Li L. Yang S. Zhao G. Li K. Association between blood groups and myocardial injury after non-cardiac surgery: A retrospective cohort study. Sci. Rep. 2024 14 1 14028 10.1038/s41598‑024‑61546‑w 38890319
    [Google Scholar]
  14. Lilova Z. Hassan F. Riaz M. Ironside J. Ken-Dror G. Han T. Sharma P. Blood group and ischemic stroke, myocardial infarction, and peripheral vascular disease: A meta-analysis of over 145,000 cases and 2,000,000 controls. J. Stroke Cerebrovasc. Dis. 2023 32 8 107215 10.1016/j.jstrokecerebrovasdis.2023.107215 37336185
    [Google Scholar]
  15. Schwarzinger M. Watson V. Arwidson P. Alla F. Luchini S. COVID-19 vaccine hesitancy in a representative working-age population in France: A survey experiment based on vaccine characteristics. Lancet Public Health 2021 6 4 e210 e221 10.1016/S2468‑2667(21)00012‑8 33556325
    [Google Scholar]
  16. Arena R. Pronk N.P. Kottke T.E. Woodard C. The lifestyle health index in the context of COVID-19 mortality and vaccination in the United States: A syndemic not to be repeated. Curr. Probl. Cardiol. 2024 49 9 102728 10.1016/j.cpcardiol.2024.102728 38944225
    [Google Scholar]
  17. Marcec R. Likic R. Using Twitter for sentiment analysis towards AstraZeneca/Oxford, Pfizer/BioNTech and Moderna COVID-19 vaccines. Postgrad. Med. J. 2022 98 1161 544 550 10.1136/postgradmedj‑2021‑140685 34373343
    [Google Scholar]
  18. Hana D. Patel K. Roman S. Gattas B. Sofka S. Clinical cardiovascular adverse events reported post-COVID-19 vaccination: Are they a real risk? Curr. Probl. Cardiol. 2022 47 3 101077 10.1016/j.cpcardiol.2021.101077 34902392
    [Google Scholar]
  19. Rahman N. Ali M.H. Sawhney A. Vyas A. Gupta R. Cardiac manifestations of COVID-19: An overview. Management, Body Systems, and Case Studies in COVID-19 Academic Press 2024 19 311 323 10.1016/B978‑0‑443‑18703‑2.00034‑7
    [Google Scholar]
  20. Webb Hooper M. Nápoles A.M. Pérez-Stable E.J. COVID-19 and racial/ethnic disparities. JAMA 2020 323 24 2466 2467 10.1001/jama.2020.8598 32391864
    [Google Scholar]
  21. Lima Dos Santos C.C. Matharoo A.S. Pinzón Cueva E. Amin U. Perez Ramos A.A. Mann N.K. Maheen S. Butchireddy J. Falki V.B. Itrat A. Rajkumar N. Zia ul Haq M. The influence of sex, age, and race on coronary artery disease: A narrative review. Cureus 2023 15 10 e47799 10.7759/cureus.47799 38021526
    [Google Scholar]
  22. Hrycek E. Walawska-Hrycek A. Milewski K. Nowakowski P. Buszman P. Żurakowski A. The influence of SARS-CoV-2 vaccination on the mortality and outcomes of patients with both myocardial infarction and COVID-19. Vaccines 2024 12 9 983 10.3390/vaccines12090983 39340015
    [Google Scholar]
  23. Elumalai K. Srinivasan S. Shanmugam A. Impact of COVID-19 vaccines on liver function: A state of the art and challenges for healthcare providers. Gastrointest. Endosc 2024 2 1 42 51
    [Google Scholar]
  24. Neshat S. Rezaei A. Farid A. Javanshir S. Dehghan Niri F. Daneii P. Heshmat-Ghahdarijani K. Sotoudehnia Korani S. Cardiovascular diseases risk predictors: ABO blood groups in a different role. Cardiol. Rev. 2024 32 2 174 179 10.1097/CRD.0000000000000463 35679024
    [Google Scholar]
  25. Reddy P.K.M. Kumar S. Birajdar A.V. Syed I. Srinivas R. The significance of von willebrand factor antigen levels in predicting the severity of coronary artery disease in patients with ST-Segment elevation myocardial infarction. IJCC 2024 5 3 237 242
    [Google Scholar]
  26. Smith D.R. Lim S.T. Murphy S.J.X. Hickey F.B. Offiah C. Murphy S.M. Collins D.R. Coughlan T. O’Neill D. Egan B. O’Donnell J.S. O’Sullivan J.M. McCabe D.J.H. von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in TIA or ischaemic stroke patients changing antiplatelet therapy. J. Neurol. Sci. 2024 463 123118 10.1016/j.jns.2024.123118 39024743
    [Google Scholar]
  27. Cheon E.J. Oh J.S. Hemolytic anemia associated with intravenous immunoglobulin in Kawasaki disease. BMC Pediatr. 2024 24 1 69 10.1186/s12887‑024‑04546‑z 38245705
    [Google Scholar]
  28. Conrad N. Molenberghs G. Verbeke G. Zaccardi F. Lawson C. Friday J.M. Su H. Jhund P.S. Sattar N. Rahimi K. Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: Population based study. BMJ 2024 385 e078523
    [Google Scholar]
  29. Janssen H. Koekkoek L.L. Swirski F.K. Effects of lifestyle factors on leukocytes in cardiovascular health and disease. Nat. Rev. Cardiol. 2024 21 3 157 169 10.1038/s41569‑023‑00931‑w 37752350
    [Google Scholar]
  30. de Frel D.L. Atsma D.E. Pijl H. Seidell J.C. Leenen P.J.M. Dik W.A. van Rossum E.F.C. The impact of obesity and lifestyle on the immune system and susceptibility to infections such as COVID-19. Front. Nutr. 2020 7 597600 10.3389/fnut.2020.597600 33330597
    [Google Scholar]
  31. Lowry M.T.H. Doudesis D. Wereski R. Kimenai D.M. Tuck C. Ferry A.V. Bularga A. Taggart C. Lee K.K. Chapman A.R. Shah A.S.V. Newby D.E. Mills N.L. Anand A. Influence of age on the diagnosis of myocardial infarction. Circulation 2022 146 15 1135 1148 10.1161/CIRCULATIONAHA.122.059994 36106552
    [Google Scholar]
  32. Norouzzadeh M. Teymoori F. Farhadnejad H. Moslehi N. Rahideh S.T. Mirmiran P. Azizi F. The interaction between diet quality and cigarette smoking on the incidence of hypertension, stroke, cardiovascular diseases, and all-cause mortality. Sci. Rep. 2024 14 1 12371 10.1038/s41598‑024‑62616‑9 38811588
    [Google Scholar]
  33. Alqahtani B.A. Alenazi A.M. A national perspective on cardiovascular diseases in Saudi Arabia. BMC Cardiovasc. Disord. 2024 24 1 184 10.1186/s12872‑024‑03845‑8 38539109
    [Google Scholar]
  34. Al-Khlaiwi T. Habib S.S. Bayoumy N. Al-Khliwi H. Meo S.A. Identifying risk factors and mortality rate of premature coronary artery disease in young Saudi population. Sci. Rep. 2024 14 1 12727 10.1038/s41598‑024‑62970‑8 38830947
    [Google Scholar]
  35. Yang W.Y. Nguyen B. Wu S. Yu J. Wang H. Yang X. Frontiers Media S.A. Editorial: Highlights for cardiovascular therapeutics in 2021 – Trained immunity, immunometabolism, gender differences of cardiovascular diseases, and novel targets of cardiovascular therapeutics. Front. Cardiovasc. Med. 2022 9 892288
    [Google Scholar]
  36. Koubaa-Ghorbel F. Chaâbane M. Jdidi H. Turki M. Makni-Ayadi F. El Feki A. Salvia officinalis mitigates uterus and liver damages induced by an estrogen deficiency in ovariectomized rats. J. Food Biochem. 2021 45 5 e13542 10.1111/jfbc.13542 33124046
    [Google Scholar]
  37. Er-Lukowiak M. Hänzelmann S. Rothe M. Moamenpour D.T. Hausmann F. Khatri R. Hansen C. Boldt J. Bärreiter V.A. Honecker B. Bea A. Groneberg M. Fehling H. Marggraff C. Cadar D. Bonn S. Sellau J. Lotter H. Testosterone affects type I/type II interferon response of neutrophils during hepatic amebiasis. Front. Immunol. 2023 14 1279245 10.3389/fimmu.2023.1279245 38179044
    [Google Scholar]
  38. Dunn S.E. Perry W.A. Klein S.L. Mechanisms and consequences of sex differences in immune responses. Nat. Rev. Nephrol. 2024 20 1 37 55 10.1038/s41581‑023‑00787‑w 37993681
    [Google Scholar]
  39. Kasztelan-Szczerbińska B. Surdacka A. Celiński K. Roliński J. Zwolak A. Miącz S. Szczerbiński M. Prognostic significance of the systemic inflammatory and immune balance in alcoholic liver disease with a focus on gender-related differences. PLoS One 2015 10 6 e0128347 10.1371/journal.pone.0128347 26107937
    [Google Scholar]
  40. Zaher K. Basingab F. Alrahimi J. Basahel K. Aldahlawi A. Gender differences in response to COVID-19 infection and vaccination. Biomedicines 2023 11 6 1677 10.3390/biomedicines11061677 37371774
    [Google Scholar]
  41. Rosende A. DiPette D.J. Martinez R. Brettler J.W. Rodriguez G. Zuniga E. Ordunez P. HEARTS in the Americas clinical pathway. Strengthening the decision support system to improve hypertension and cardiovascular disease risk management in primary care settings. Front. Cardiovasc. Med. 2023 10 1102482 10.3389/fcvm.2023.1102482 37180772
    [Google Scholar]
  42. Akhtar Z. Trent M. Moa A. Tan T.C. Fröbert O. MacIntyre C.R. The impact of COVID-19 and COVID vaccination on cardiovascular outcomes. Eur. Heart J. Suppl. 2023 25 Suppl. A A42 A49 10.1093/eurheartjsupp/suac123 36937372
    [Google Scholar]
  43. Altman N.L. Berning A.A. Mann S.C. Quaife R.A. Gill E.A. Auerbach S.R. Campbell T.B. Bristow M.R. Vaccination-associated myocarditis and myocardial injury. Circ. Res. 2023 132 10 1338 1357 10.1161/CIRCRESAHA.122.321881 37167355
    [Google Scholar]
  44. Chen Y. Zhou X. Chen Z. Xia J. Guan F. Li Y. Li Y. Chen Y. Zhao Y. Qiu H. Liang J. Tang L. The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease. Ren. Fail. 2023 45 1 2220420 10.1080/0886022X.2023.2220420 37278148
    [Google Scholar]
  45. Banerjee P. Gaddam N. Chandler V. Chakraborty S. Oxidative stress-induced liver damage and remodeling of the liver vasculature. Am. J. Pathol. 2023 193 10 1400 1414 10.1016/j.ajpath.2023.06.002 37355037
    [Google Scholar]
  46. Crisci G. Bobbio E. Gentile P. Bromage D.I. Bollano E. Ferone E. Israr M.Z. Heaney L.M. Polte C.L. Cannatà A. Salzano A. Biomarkers in acute myocarditis and chronic inflammatory cardiomyopathy: An updated review of the literature. J. Clin. Med. 2023 12 23 7214 10.3390/jcm12237214 38068265
    [Google Scholar]
  47. Zodda E. Tura-Ceide O. Mills N.L. Tarragó-Celada J. Carini M. Thomson T.M. Cascante M. Autonomous metabolic reprogramming and oxidative stress characterize endothelial dysfunction in acute myocardial infarction. eLife 2023 12 e86260 10.7554/eLife.86260 38014932
    [Google Scholar]
  48. Berber E. Sumbria D. Kokkaya S. A metabolic blueprint of COVID-19 and long-term vaccine efficacy. Drug Metab. Pers. Ther. 2023 38 1 15 29 10.1515/dmpt‑2022‑0148 36166711
    [Google Scholar]
  49. Efe C. Kulkarni A.V. Terziroli Beretta-Piccoli B. Magro B. Stättermayer A. Cengiz M. Clayton-Chubb D. Lammert C. Bernsmeier C. Gül Ö. la Tijera F.H. Anders M. Lytvyak E. Akın M. Purnak T. Liberal R. Peralta M. Ebik B. Duman S. Demir N. Balaban Y. Urzua Á. Contreras F. Venturelli M.G. Bilgiç Y. Medina A. Girala M. Günşar F. Londoño M.C. Androutsakos T. Kisch A. Yurci A. Güzelbulut F. Çağın Y.F. Avcı E. Akyıldız M. Dindar-Demiray E.K. Harputluoğlu M. Kumar R. Satapathy S.K. Mendizabal M. Silva M. Fagiuoli S. Roberts S.K. Soylu N.K. Idilman R. Yoshida E.M. Montano-Loza A.J. Dalekos G.N. Ridruejo E. Schiano T.D. Wahlin S. Liver injury after SARS‐CoV‐2 vaccination: Features of immune‐mediated hepatitis, role of corticosteroid therapy and outcome. Hepatology 2022 76 6 1576 1586 10.1002/hep.32572 35567545
    [Google Scholar]
  50. Lala V. Zubair M. Minter D. Liver function tests. StatPearls 2023
    [Google Scholar]
  51. Nakafero G. Grainge M.J. Card T. Mallen C.D. Nguyen Van-Tam J.S. Abhishek A. Effectiveness of pneumococcal vaccination in adults with common immune-mediated inflammatory diseases in the UK: A case–control study. Lancet Rheumatol. 2024 6 9 e615 e624 10.1016/S2665‑9913(24)00128‑0 39067457
    [Google Scholar]
  52. Lee S. Lee J. Cho S.H. Roh G. Park H.J. Lee Y.J. Jeon H.E. Lee Y.S. Bae S.H. Youn S.B. Cho Y. Oh A. Ha D. Lee S.Y. Choi E.J. Cho S. Lee S. Kim D.H. Kang M.H. Yoon M.S. Lim B.K. Nam J.H. Assessing the impact of mRNA vaccination in chronic inflammatory murine model. NPJ Vaccines 2024 9 1 34 10.1038/s41541‑024‑00825‑z 38360752
    [Google Scholar]
  53. van Dorst M.M.A.R. Pyuza J.J. Nkurunungi G. Kullaya V.I. Smits H.H. Hogendoorn P.C.W. Wammes L.J. Everts B. Elliott A.M. Jochems S.P. Yazdanbakhsh M. Immunological factors linked to geographical variation in vaccine responses. Nat. Rev. Immunol. 2024 24 4 250 263 10.1038/s41577‑023‑00941‑2 37770632
    [Google Scholar]
  54. Kashimura M. Blood defense system – Proposal for a new concept of an immune system against blood borne pathogens comprising the liver, spleen and bone marrow. Scand. J. Immunol. 2024 99 5 e13363 10.1111/sji.13363 38605529
    [Google Scholar]
  55. Krishna B.A. Metaxaki M. Sithole N. Landín P. Martín P. Salinas-Botrán A. Cardiovascular disease and covid-19: A systematic review. Int. J. Cardiol. Heart Vasc. 2024 54 101482 10.1016/j.ijcha.2024.101482 39189008
    [Google Scholar]
  56. Badmus O.O. da Silva A.A. Li X. Taylor L.C. Greer J.R. Wasson A.R. McGowan K.E. Patel P.R. Stec D.E. Cardiac lipotoxicity and fibrosis underlie impaired contractility in a mouse model of metabolic dysfunction‐associated steatotic liver disease. FASEB Bioadv. 2024 6 5 131 142 10.1096/fba.2023‑00139 38706754
    [Google Scholar]
  57. Bali A.D. Rosenzveig A. Frishman W.H. Aronow W.S. Nonalcoholic fatty liver disease and cardiovascular disease: Causation or association. Cardiol. Rev. 2024 32 5 453 462 10.1097/CRD.0000000000000537 36825899
    [Google Scholar]
  58. Rako Z.A. Yogeswaran A. Yildiz S. Weidemann P. Zedler D. da Rocha B.B. Kryvenko V. Schäfer S. Ghofrani H.A. Seeger W. Kremer N.C. Tello K. Liver stiffness is associated with right heart dysfunction, cardiohepatic syndrome, and prognosis in pulmonary hypertension. J. Heart Lung Transplant. 2024 43 7 1105 1115 10.1016/j.healun.2024.02.013 38373557
    [Google Scholar]
/content/journals/cvp/10.2174/0115701611362338250214103331
Loading
Evaluation of Cardiovascular and Hepatic Changes in Myocardial Infarction Patients Post-Covid-19 Vaccination
Bentham Science Publishers ; https://doi.org/10.2174/0115701611362338250214103331
/content/journals/cvp/10.2174/0115701611362338250214103331
/content/journals/cvp/10.2174/0115701611362338250214103331
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

file format download Download

  • Article Type:     Research Article
Keywords: Hepatic complications ; Covid-19 vaccine ; Adverse effects ; hypertension ; Myocardial infarction

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test